|
Market Closed -
Australian S.E.
01:10:10 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.2100 AUD | -4.55% |
|
-4.55% | -61.82% |
| 11:16pm | Dimerix Chair to Retire | MT |
| 10-15 | Dimerix Says First 100 Patients Enrolled in Phase 3 Kidney Disease Clinical Trial Complete Two-Year Double-Blind Treatment Period | MT |
Company Valuation: Dimerix Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 38.61 | 38.5 | 24.06 | 280.6 | 344.1 | 123.1 |
| Change | - | -0.27% | -37.52% | 1,066.27% | 22.65% | -64.24% |
| Enterprise Value (EV) 1 | 38.45 | 28.95 | 22.03 | 258.6 | 276 | 107.2 |
| Change | - | -24.72% | -23.91% | 1,074.12% | 6.71% | -61.17% |
| P/E | -6.06x | -3.37x | -1.46x | -13.5x | -24.3x | -4.13x |
| PBR | 26.3x | 2.67x | 4.03x | 15.4x | 25.7x | -8.34x |
| PEG | - | -0.3x | -0.1x | 1.2x | 0.7x | -0x |
| Capitalization / Revenue | 8.7x | 5.96x | 2.68x | 481x | 61.6x | 19.4x |
| EV / Revenue | 8.66x | 4.48x | 2.45x | 443x | 49.4x | 16.9x |
| EV / EBITDA | -5.93x | -2.76x | -1.59x | -15.2x | -8.62x | -3.05x |
| EV / EBIT | -5.93x | -2.76x | -1.59x | -15.1x | -8.62x | -3.05x |
| EV / FCF | -9.1x | -2.91x | -2.9x | -21.9x | 48.8x | -2.21x |
| FCF Yield | -11% | -34.4% | -34.5% | -4.56% | 2.05% | -45.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0356 | -0.0424 | -0.0377 | -0.0236 | -0.0497 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 4.44 | 6.466 | 8.984 | 0.5835 | 5.587 | 6.354 |
| EBITDA 1 | -6.479 | -10.49 | -13.84 | -17.07 | -32 | -35.16 |
| EBIT 1 | -6.488 | -10.49 | -13.84 | -17.08 | -32.01 | -35.17 |
| Net income 1 | -6.372 | -10.49 | -13.8 | -17.08 | -13.25 | -29.81 |
| Net Debt 1 | -0.157 | -9.557 | -2.034 | -21.99 | -68.19 | -15.92 |
| Reference price 2 | 0.1950 | 0.1200 | 0.0620 | 0.5100 | 0.5750 | 0.2050 |
| Nbr of stocks (in thousands) | 197,999 | 320,874 | 388,059 | 550,196 | 598,511 | 600,397 |
| Announcement Date | 8/15/21 | 8/28/22 | 8/29/23 | 8/28/24 | 8/27/25 | 8/26/26 |
1AUD in Million2AUD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 91.91M | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 26.11x | 26.57x | 15.32x | 0.32% | 37.25B | |
| Weighted average by Cap. | 25.97x | 25.01x | 15.48x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DXB Stock
- Valuation Dimerix Limited
Select your edition
All financial news and data tailored to specific country editions
